Accessibility: Skip TopNav
LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Now Available in Japan for Patients with Early Alzheimer’s Disease
The First and Only Anti-Amyloid Treatment in Japan that Enables At-Home Administration
Format
PNG
Source
Biogen Inc.
Téléchargements
Original
Grand
Moyen
Petit